Cameron Criswell

This paper designs antibodies de novo with atomic precision using RFdiffusion and yeast display, validated by cryo-EM and biophysical methods.

This study designs protein minibinders that act as agonists for TLR3, showing nanomolar binding and biological activity in cell lines.